Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Ironwood Pharmaceuticals (IRWD) over the last 7 years, with Q3 2025 value amounting to 0.95%.

  • Ironwood Pharmaceuticals' Return on Invested Capital fell 4800.0% to 0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.95%, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of 0.26% for FY2024, which is 37500.0% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Return on Invested Capital is 0.95%, which was down 4800.0% from 0.22% recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Return on Invested Capital registered a high of 7.59% during Q1 2024, and its lowest value of 3.45% during Q2 2023.
  • In the last 5 years, Ironwood Pharmaceuticals' Return on Invested Capital had a median value of 0.31% in 2022 and averaged 1.24%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first soared by 99300bps in 2021, then plummeted by -76900bps in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.86% in 2021, then plummeted by -68bps to 0.28% in 2022, then surged by 2556bps to 7.42% in 2023, then crashed by -103bps to 0.19% in 2024, then crashed by -407bps to 0.95% in 2025.
  • Its last three reported values are 0.95% in Q3 2025, 0.22% for Q2 2025, and 0.09% during Q1 2025.